| 000 | 01078 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517084850.0 | ||
| 264 | 0 | _c20180131 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2016.03.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAggarwal, Rahul | |
| 245 | 0 | 0 |
_aPrednisone Use in Conjunction with Abiraterone Acetate: Is Patient Safety a Concern with Long-term Steroid Exposure? _h[electronic resource] |
| 260 |
_bEuropean urology _c09 2016 |
||
| 300 |
_a445-6 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAbiraterone Acetate |
| 650 | 0 | 4 | _aAntineoplastic Agents, Hormonal |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aPrednisone |
| 650 | 0 | 4 | _aProstatic Neoplasms, Castration-Resistant |
| 650 | 0 | 4 | _aSteroid 17-alpha-Hydroxylase |
| 773 | 0 |
_tEuropean urology _gvol. 70 _gno. 3 _gp. 445-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2016.03.018 _zAvailable from publisher's website |
| 999 |
_c25842279 _d25842279 |
||